Advertisement

Elimination of pancoast tumor by carboplatin, paclitaxel, and concurrent radiation

  • Tomoki Utsumi
  • Yuko Suzuki
  • Yoshiaki Sasaki
  • Midori Tamura
  • Kiyoshi Ohno
Case Report
  • 34 Downloads

Abstract

Preoperative chemoradiotherapy with carboplatin (AUC 1.5), paclitaxel (40 mg/m2), and concurrent extracorporeal radiation (40 Gy) was used to treat a Pancoast tumor (clinical T3N0M0), without causing adverse events. Then left upper lobectomy was performed along with mediastinal lymph node dissection plus resection of the chest wall and Th, nerve root. Histological examination revealed a pathological complete response. This multimodal regimen was feasible and achieved a good response, so it seems worthwhile to evaluate the clinical effectiveness of the therapy in a cohort study.

Key words

lung cancer surgery chemotherapy radiation therapy preoperative care 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Johnson D, etal. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001; 121: 472–83.PubMedCrossRefGoogle Scholar
  2. 2.
    Pancoast HK. Superior pulmonary sulcus tumors. Tumor characterized by pain, Horner’s syndrome, destruction of bone and atrophy of hand muscles. JAMA 1932; 99: 1391–6.Google Scholar
  3. 3.
    Shaw RR, Paulson DL, Kee JL. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154: 29–40.Google Scholar
  4. 4.
    Hilaris BS, Martini N, Wong GY, Nori D. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 1987; 67: 965–77.PubMedGoogle Scholar
  5. 5.
    Rusch VW, Parekh KR, Leon L, Venkatraman E, Bains MS, Downey RJ, etal. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 2000; 119: 1147–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Martinez-Monge R, Herreros J, Aristu JJ, Aramendia JM, Azinovic I. Combined treatment in superior sulcus tumors. Am J Clin Oncol 1994; 17: 317–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Suntharalingam M, Sonett JR, Haas ML, Doyle LA, Hausner PF, Schuetz J, etal. The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors. Cancer J 2000; 6: 365–71.PubMedGoogle Scholar
  8. 8.
    Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T, etal. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 1998; 16: 3316–22.PubMedGoogle Scholar
  9. 9.
    Ratanatharathorn V, Lorvidhaya V, Maoleekoonpairoj S, Phromratanapongse P, Sirilerttrakul S, Kraipiboon P, etal. Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Lung Cancer 2001; 31: 257–65.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Association for Thoracic Surgery 2004

Authors and Affiliations

  • Tomoki Utsumi
    • 2
  • Yuko Suzuki
    • 1
  • Yoshiaki Sasaki
    • 1
  • Midori Tamura
    • 1
  • Kiyoshi Ohno
    • 2
  1. 1.Department of Internal MedicineOsaka Kosei-Nenkin HospitalOsakaJapan
  2. 2.Department of SurgeryOsaka Kosei-Nenkin HospitalOsakaJapan

Personalised recommendations